Navigation Links
ERT Announces Clearance from German Federal Cartel Office
Date:6/6/2012

PHILADELPHIA, June 6, 2012 /PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations, today announced that Genstar Capital LLC was informed that it received clearance from the German Federal Cartel Office to proceed with its proposed acquisition of ERT.

The transaction has been approved unanimously by the ERT Board of Directors, following a recommendation by a Special Committee of independent directors, and the ERT Board of Directors recommends that ERT stockholders approve the transaction.  At a meeting scheduled to occur on June 22, 2012, ERT's stockholders will vote on the approval of the merger agreement pursuant to which ERT has agreed to be acquired by affiliates of Genstar Capital LLC for $8.00 per share in cash.

About ERT

ERT (www.ERT.com) is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations (CROs) to achieve their drug development and healthcare objectives. ERT harnesses leading technology coupled with unrivaled processes and scientific expertise to collect, analyze, and report on clinical data to support the determination of health outcomes critical to the approval, labeling and reimbursement of pharmaceutical products.  ERT is the acknowledged industry leader in centralized cardiac safety and respiratory efficacy services and also provides electronic Patient Reported Outcomes (ePRO) and outcomes assessments for multiple modalities across all phases.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively inve
'/>"/>

SOURCE eResearchTechnology, Inc. (ERT)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
2. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
3. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
4. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
5. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
6. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
7. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
8. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
9. Regeneron Announces June 2012 Investor Conference Presentations
10. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
11. Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Decision Resources Group finds that the market ... $7.7 billion by 2023 in the United States ... , Italy , Spain ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s ... out by the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s ...
(Date:8/28/2014)... 28, 2014   Edison Nation Medical , ... worldwide search for product ideas to improve the ... ideas uncovered through the 6-month search ( www.EdisonNationMedical.com/Seniors ... manufacturers and healthcare retailers with whom Edison Nation ... individuals age 65 and older. The ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... 14 Jane Staveley, a Principal Environmental Scientist for ... management services company, will moderate a distinguished panel of ... Concerns and Responses" during a briefing in the Rayburn ... be held from noon to 1:30 p.m. and is ...
... NEW YORK, Sept. 14 Reportlinker.com announces ... available in its catalogue: ... Assessment and Market Forecasts to 2016 ... Global Renal Dialysis Equipment Pipeline Analysis, ...
Cached Medicine Technology:ARCADIS' Jane Staveley to Moderate Congressional Briefing on Pharmaceuticals in Drinking Water 2Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 11Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 12
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... promote National Recovery Month throughout September. This month ... of addiction treatment and mental health services. Along ... Millennium Treatment Group is helping to spread the ... Month began in 1989, honoring the work of ...
(Date:8/28/2014)... American adults who are beginning to research ... now have a simpler way to connect with companies ... year, some of the best life insurance rates available ... The promoted plans that included price data revealed to ... policies. The term, guaranteed and modified plans that might ...
(Date:8/28/2014)... 2014 ABC television stars will join ... Show of Strength Telethon airing Sunday, Aug. 31, 9/8c ... raise funds and awareness to help save and improve ... disease. , Viewers tuning into the 2014 telethon to ... and introductions from some of the network’s leading stars, ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 ... announced today a regional partnership designed to advance ... planning for competitive young athletes, scholastic athletes and ... partnership’s Strong Body & Mind Initiative will offer ... both the physical and mental dynamics involved in ...
(Date:8/28/2014)... 28, 2014 Gurnick Academy of Medical ... program is re-accredited for the 5 years of the ... Technologists (ARMRIT). , “We are very proud to ... our program to make sure we provide the best ... interest in MRI field nowadays and I look forward ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2
... Medicine have just developed an advanced imaging technique to ... white blood cells. Microdomains are restricted areas on the ... molecules accumulate during cell activation. Using digital multi-channel videomicroscopy, ... and their forming microdomains in the vascular system in ...
... national guidelines recommend that, if managed, may have prevented ... in the issue of Neurology, the scientific journal of ... study of 1,040 people hospitalized for stroke or transient ... higher than recommended by national guidelines. TIA happens when ...
... But they are still just as sensitive as anyone else. Ignoring ... so//. ,Members of the "stronger sex" often expect a ... Many only consult a doctor when it's too late and could ... ,German men have a life expectancy of around 76 years, compared ...
... who smoke are increasingly at the risk of becoming ... turn into active TB disease//, according to an analysis ... Medicine. ,About one-third of the world’s population is ... the organism is usually rendered inactive by the immune ...
... molecular mechanisms behind most of the body’s sensing capabilities. Vision, ... pigment molecule that is extremely sensitive to light. It is ... decoded by the brain into visual information. But how the ... temperature has remained a mystery. ,“For a ...
... drug Vandetanib, marketed by London company AstraZeneca PLC// has begun. ... of lung cancer in whom the first-line treatment has failed. ... , The patients who have a recorded a case ... be given the once-daily drug Vandetanib in addition to pemetrexed, ...
Cached Medicine News:Health News:New Imaging Technique Tracks Traffic Patterns of White Blood Cells 2Health News:Cholesterol in Stroke Patients Exceeds National Guidelines 2Health News:Men Not as Tough as They Seem 2Health News:Susceptibility to TB is High Among the Smokers 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 3
This aron protects at 0.5 mm Pb equivalency and is 20% lighter than our Standard Back-Aid Apron - yet it contains no lead products that can be harmful to the environment!...
Protect your thyroid with a personal Thyroid Shield. While other shields have a rough, abrasive bias binding edging the neck, these have a softer, smoother turned seam that helps protect your neck fr...
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Medicine Products: